Andere Sprachen Chordate Medical Holding AB

Aktien

A2DJ60

SE0009495559

CMH

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 17:29:46 03.05.2024			% 5 Tage	% 1. Jan.
0,061 ^SEK	-3,79 %		+9,32 %	-61,97 %

22.03.	Chordate Medical Holding AB (publ) berichtet über die Ergebnisse für das Geschäftsjahr zum 31. Dezember 2023	CI
22.03.	Chordate Medical Holding AB (publ) meldet Ergebnis für das vierte Quartal bis zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Chordate will be granted a fourth patent in the USA	03.05.
Chordate's board member to BioStock: "Women's health is a concern for society at large"	30.04.
Chordate presents Ozilia at LSX World Congress on April 29-30	25.04.
Chordate presents Ozilia to national specialist associations from Germany, Switzerland, & Austria	22.04.
Chordate presents at the Feminvest investor conference in Oslo	18.04.
Chordate Medical Holding AB (publ) Appoints Lago Kapital as Liquidity Provider	18.04.
Notice to the Annual General Meeting in Chordate Medical Holding AB (publ)	15.04.
Chordate Medical Holding AB publishes annual report for 2023	12.04.
BioStock: Chordate comments on Q4 and case report	03.04.
Chordate Medical's CEO Anders Weilandt interviewed about year-end report by Finwire	26.03.
Year-End Report Chordate Medical Holding AB (publ) January - December 2023	22.03.
Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	22.03.
Chordate Medical Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22.03.
Chordate Medical presents Year-end report for 2023 on Finwire TV	21.03.
BioStock: Chordate's CEO presented at Swiss Nordic Bio	12.03.
New case report with Ozilia published: "Effective for both pain relief and reduced frequency of migraine attacks"	11.03.
Chordate Medical's CEO to attend investor conference in Switzerland	29.02.
Chordate Medical publishes outcome in rights issue	20.02.
The German Migraine Market and the Potential for Chordate Medical	20.02.
Last day for subscription in Chordate Medical	16.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Chordate Medical Holding AB

Aktien

A2DJ60

SE0009495559

CMH

Andere Sprachen

Filter